Permeability for intestinal absorption: Caco-2 assay and related issues

Area of Science:

• Pharmacology
• Drug Discovery
• Biotechnology

Background:

• In vitro permeability assays are crucial for optimizing drug candidates.
• Predicting oral bioavailability requires robust in vitro to in vivo correlation.
• The Caco-2 assay is a widely used cell-based model for intestinal permeability screening.

Purpose of the Study:

• To review the strengths and limitations of the Caco-2 permeability assay.
• To discuss strategies for improving the predictability of in vitro permeability data.
• To highlight the importance of early assessment of efflux liability in drug development.

Main Methods:

• Review of existing literature on Caco-2 permeability assays.
• Discussion of technical challenges like low solubility and recovery.
• Analysis of combining Caco-2 data with other assays and in silico models.

Main Results:

• The Caco-2 assay offers valuable insights into intestinal permeability and efflux.
• Limitations include potential for misleading results and technical challenges.
• Combining multiple assays improves prediction accuracy for lead optimization.

Conclusions:

• The Caco-2 assay remains a relevant tool, especially for efflux liability screening.
• Addressing in vitro assay limitations and combining approaches enhances drug development predictability.
• Careful interpretation of Caco-2 data is essential for accurate in vivo correlation.